Investors login
Menu
Investors login
Menu

News: 2021

Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms

January 06, 2021
• First joint CriVac® vaccine candidate to target receptor-binding domain of SARS-CoV-2 • Evaluation of Cristal's CliCr® and I...
Read more
Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms
Previous 1 2 3
Meet us at
Events
Dutch Life Sciences 2023
Leiden, The Netherlands, 7 december 2023
JPM 2024 42nd Annual Healthcare Conference
San Francisco, United States, 8 / 11 january 2024
Archives
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Meet us at
Dutch Life Sciences 2023
Leiden, The Netherlands, 7 december 2023
JPM 2024 42nd Annual Healthcare Conference
San Francisco, United States, 8 / 11 january 2024
More events
Meet us at
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development
November 29, 2023
Strategic joint marketing agreement MIMETAS and Yamaha Motor.
More events

Home > News > Archive

Contact
Businesspark Berg en Bosch
Prof. Bronkhorstlaan 10, building 92
3723 MB Bilthoven
T +31 (0)30 - 229 60 90
F +31 (0)30 - 229 60 99
info@aglaia-oncology.com
Aglaia Management B.V. is registered with the Trade Register of the Chamber of Commerce and Industry under number 54970857.
© 2023 Aglaia Oncology Funds | Privacy | Sitemap
Aglaia Oncology Funds